CorporateProfile

Forte Biosciences is a clinical-stage biopharmaceutical company focused on dermatology. Forte’s lead product, FB-401, is a live biotherapeutic for the treatment of inflammatory skin disease developed in collaboration with the National Institute of Health (“NIH”), and the National Institute of Allergy and Infectious Diseases (“NIAID”).

Learn More

Latest Press releases

RecentEvents

All Events

FeaturedPresentation